Endothelin-1 Regulates Oligodendrocyte Development

被引:61
|
作者
Gadea, Ana [1 ]
Aguirre, Adan [1 ]
Haydar, Tarik F. [1 ]
Gallo, Vittorio [1 ]
机构
[1] Childrens Natl Med Ctr, Neurosci Res Ctr, Childrens Res Inst, Washington, DC 20010 USA
来源
JOURNAL OF NEUROSCIENCE | 2009年 / 29卷 / 32期
基金
美国国家卫生研究院;
关键词
ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; PROGENITOR CELLS; ASTROCYTE PROLIFERATION; SUBVENTRICULAR ZONE; PRIMARY CULTURES; BINDING-SITES; SCHWANN-CELLS; OPTIC-NERVE; SPINAL-CORD;
D O I
10.1523/JNEUROSCI.0822-09.2009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In the postnatal brain, oligodendrocyte progenitor cells (OPCs) arise from the subventricular zone (SVZ) and migrate into the developing white matter, where they differentiate into oligodendrocytes and myelinate axons. The mechanisms regulating OPC migration and differentiation are not fully defined. The present study demonstrates that endothelin-1 (ET-1) is an astrocyte-derived signal that regulates OPC migration and differentiation. OPCs in vivo and in culture express functional ETA and ETB receptors, which mediate ET-1-induced ERK (extracellular signal-regulated kinase) and CREB (cAMP response element-binding protein) phosphorylation. ET-1 exerts both chemotactic and chemokinetic effects on OPCs to enhance cell migration; it also prevents lineage progression from the O4(+) to the O1(+) stage without affecting cell proliferation. Astrocyte-conditioned medium stimulates OPC migration in culture through ET receptor activation, whereas multiphoton time-lapse imaging shows that selective ET receptor antagonists or anti-ET-1 antibodies inhibit OPC migration from the SVZ. Inhibition of ET receptor activity also derepresses OPC differentiation in the corpus callosum in slice cultures. Our findings indicate that ET-1 is a soluble astrocyte-derived signal that regulates OPC migration and differentiation during development.
引用
收藏
页码:10047 / 10062
页数:16
相关论文
共 50 条
  • [41] Endothelin-1 and antiangiogenesis
    Lankhorst, Stephanie
    Danser, A. H. Jan
    van den Meiracker, Anton H.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2016, 310 (03) : R230 - R234
  • [42] Dose of endothelin-1
    Tessier-Vetzel, D.
    POINT VETERINAIRE, 2006, 37 (271): : 8 - 8
  • [43] ENDOTHELIN-1 IN HEATSTROKE
    BOUCHAMA, A
    HAMMAMI, MM
    JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (04) : 1391 - 1391
  • [44] Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients
    Ottosson-Seeberger, A
    Ahlborg, G
    Hemsén, A
    Lundberg, JM
    Alvestrand, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (05): : 1037 - 1044
  • [45] PHOSPHORAMIDON INHIBITS THE CONVERSION OF INTRACISTERNALLY ADMINISTERED BIG ENDOTHELIN-1 TO ENDOTHELIN-1
    SHINYAMA, H
    UCHIDA, T
    KIDO, H
    HAYASHI, K
    WATANABE, M
    MATSUMURA, Y
    IKEGAWA, R
    TAKAOKA, M
    MORIMOTO, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (01) : 24 - 30
  • [46] EFFECTS OF PHOSPHORAMIDON IN ENDOTHELIAL-CELL CULTURES ON THE ENDOGENOUS SYNTHESIS OF ENDOTHELIN-1 AND ON CONVERSION OF EXOGENOUS BIG ENDOTHELIN-1 TO ENDOTHELIN-1
    CORDER, R
    HARRISON, VJ
    KHAN, N
    ANGGARD, EE
    VANE, JR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 : S73 - S76
  • [47] BIG ENDOTHELIN-1 IS CONVERTED TO ENDOTHELIN-1 IN THE ISOLATED PERFUSED RABBIT LUNGS
    ONIZUKA, M
    ISHIKAWA, S
    TSUKADA, H
    YUASA, H
    FUKUE, M
    WEI, S
    MIYAUCHI, T
    ISHIKAWA, T
    MITSUI, K
    GOTO, K
    HORI, M
    FASEB JOURNAL, 1991, 5 (05): : A1428 - A1428
  • [48] ENDOTHELIN-1 AND BIG ENDOTHELIN-1 INCREASE IN HUMAN ENDOMETRIUM DURING MENSTRUATION
    OHBUCHI, H
    NAGAI, K
    YAMAGUCHI, M
    IKENOUE, T
    MORI, N
    KITAMURA, K
    ARAKI, S
    TOSHIMORI, K
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (05) : 1483 - 1490
  • [49] Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension
    Kostov, Krasimir
    Blazhev, Alexander
    PATHOPHYSIOLOGY, 2021, 28 (04) : 489 - 495
  • [50] Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?
    Ozdogan, O
    Goren, Z
    Tozun, N
    Moini, H
    Bilsel, S
    Celikel, C
    Kalayci, C
    Berkman, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1354 - A1354